Smoking and risk of multiple sclerosis: Evidence of modification by NAT1 variants

Epidemiology

Volumn 25, Issue 4, 2014, Pages 605-614

  Briggs, Farren B S ^a   Acuna, Brigid ^b   Shen, Ling ^b   Ramsay, Patricia ^a   Quach, Hong ^a   Bernstein, Allan ^c   Bellesis, Kalliope H ^b   Kockum, Ingrid S ^d   Hedström, Anna K ^d   Alfredsson, Lars ^d   Olsson, Tomas ^d   Schaefer, Catherine ^b   Barcellos, Lisa F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Palm Drive Hospital   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; NAT2 PROTEIN; NORADRENALIN TRANSPORTER; PROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG; AAP1 PROTEIN, ARABIDOPSIS; AMINO ACID TRANSPORTER; ARABIDOPSIS PROTEIN; ARYLAMINE ACETYLTRANSFERASE; GSTP1 PROTEIN, HUMAN; ISOENZYME; N-ACETYLTRANSFERASE 1; PASSIVE SMOKING;

ADULT; ARTICLE; BINDING SITE; CAUCASIAN; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION EXPOSURE; PRIORITY JOURNAL; REPLICATION STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SWEDEN; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; PASSIVE SMOKING; RISK FACTOR; UNITED STATES;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ARABIDOPSIS PROTEINS; ARYLAMINE N-ACETYLTRANSFERASE; CALIFORNIA; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; SWEDEN; TOBACCO SMOKE POLLUTION;

EID: 84902245525     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000089     Document Type: Article

References (41)

1. Hawkes CH, Macgregor AJ. Twin studies and the heritability of MS: a conclusion. Mult Scler. 2009;15:661-667.
2. Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun. 2005;6:375-387.
3. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15:2813-2824.
4. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214-219.
5. International Multiple Sclerosis Genetics Consortium (IMSGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013;45:1353-1360.
6. Manolio TA , Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747-753.
7. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288-299.
8. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann Neurol. 2007;61:504-513.
9. Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler. 2007;13:610-615.
10. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. Smoking and multiple sclerosis: an updated meta- analysis. PLoS One. 2011;6:e16149.
11. Hedström AK, Sundqvist E, Bäärnhielm M, et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain. 2011;134(pt 3):653-664.
12. Green CR, Rodgman A. The Tobacco Chemists' Research Conference: a half century forum for advances in analytical methodology of tobacco and its products. Rec Adv Tob Sci. 1996;22: 131-304.
13. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci. 1993;686: 12-27; discussion 27
14. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol. 2001;14:767-790.
15. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology. 2009;73:696-701.
16. Mikaeloff Y, Caridade G, Tardieu M, Suissa S; KIDSEP study group. Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain. 2007;130:2589-2595.
17. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler. 2011;17:788-793.
18. Goldstein JA, Faletto MB. Advances in mechanisms of activation and deactivation of environmental chemicals. Environ Health Perspect. 1993;100:169-176.
19. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006;21:257-276.
20. Sanderson S, Salanti G, Higgins J. Joint effects of the N-acetyltransferase 1 and 2 (NAT 1 and NAT 2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. Am J Epidemiol. 2007;166:741-751.
21. Keenan BT, Chibnik LB, Cui J, et al. Effect of interactions of glutathione S-transferase T1, M1, and P1 and HMOX1 gene promoter polymorphisms with heavy smoking on the risk of rheumatoid arthritis. Arthritis Rheum. 2010;62:3196-3210.
22. Kilfoy BA, Zheng T, Lan Q, et al. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2010;21:127-133.
23. Cox DG, Dostal L, Hunter DJ, et al; Breast and Prostate Cancer Cohort Consortium. N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium. Am J Epidemiol. 2011;174:1316-1322.
24. Zhang ZJ, Hao K, Shi R, et al. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis. Am J Epidemiol. 2011;173:847-857.
25. Walker K, Ginsberg G, Hattis D, Johns DO, Guyton KZ, Sonawane B. Genetic polymorphism in N-Acetyltransferase (NAT ): Population distribution of NAT 1 and NAT 2 activity. J Toxicol Environ Health B Crit Rev. 2009;12:440-472.
26. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
27. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58:840-846.
28. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44:955-959.
29. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole- genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559-575.
30. Hein DW, Doll MA. Accuracy of various human NAT 2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes. Pharmacogenomics. 2012;13:31-41.
31. Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol. 2010;34:816-834.
32. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
33. Johnson RC, Nelson GW, Troyer JL, et al. Accounting for multiple comparisons in a genome-wide association study (GWAS). BMC Genomics. 2010;11:724.
34. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930-D934.
35. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11:259-272.
36. Goodin DS. The causal cascade to multiple sclerosis: a model for MS pathogenesis. PLoS One. 2009;4:e4565.
37. Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat Rev Neurol. 2010;6:156-166.
38. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol. 2010;28: 817-825.
39. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473:43-49.
40. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet. 2010;11:259-272.
41. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb). 2005;95: 221-227. Stroke Stroke